UPDATE 2-Mallinckrodt to pay $100 mln to settle U.S. probe on drug pricing

WASHINGTON, Jan 18 (Reuters) - Mallinckrodt Plc has

agreed to pay $100 million to settle allegations that a

subsidiary broke U.S. antitrust law by sharply increasing the

price of a multiple sclerosis...

Read more